Effect of drug coated balloon therapy on endovascular response and hemodynamics in patients with intradialysis fistula restenosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500102680

Enrollment

Unknown

Registered

2025-05-19

Start date

2023-07-03

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular access

Interventions

Experimental group:Paclitaxel balloon PTA was performed

control group:Perform the common balloon PTA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Recurrent AVF stenosis; (2) The first treatment of PTA was conventional balloon dilatation; (3) A single vein Stenosis lesion; (4) The fistula vein is mature, and the diameter of the normal part is greater than 5 mm.

Exclusion criteria

Exclusion criteria: (1) Patients with extensive thrombosis in local focal vessels; (2) Allergic to paclitaxel; (3) Hemodialysis puncture is difficult to perform; (4) Those with unstable vital signs; (5) Severe coagulation function Persons with disabilities; (6) AVF infected persons; (7) AVF thrombosis; (8) Target lesions across joints; (9) There were signs of central venous disease

Design outcomes

Primary

Measure	Time frame
minimum lumen diameter,MLD;late lumen loss, LLL;Target lesion revascularization rate;peak systolic velocity,PSV;target lesion primary patency, TLPP;	—

Countries

China

Contacts

Public ContactCe Zhang

Nanjing Gulou Hospital Group Suqian Hospital

gu.zhumei@163.com+86 183 5139 6152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026